Key facts
- Lauduz’s last known valuation is $25.0M (Apr 2026).
- It has raised $5.0M; the latest was Early Stage VC ($5.0M) in Apr 2026.
- Notable investors include Biominas Brasil, Oxigenio Aceleradora, Quartzo Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Lauduz
- ·The full record, as it builds
Funding rounds
No funding rounds for Lauduz are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lauduz
Provider of a software platform designed for business operations management purpose. The company's platform includes tools for workflow configuration, data integration, user access control, reporting dashboards, and process automation capabilities, supporting coordination across departments and enabling businesses across various industries to manage operational tasks, streamline internal processes, improve data visibility, and maintain consistency in execution without reliance on fragmented systems.
- Sector
- Healthcare
- HQ
- Santa Mari, Brazil
- Founded
- 2021
- Employees
- 19
- Website
- lauduz.com/
- Ownership
- Privately Held (backing)
Lauduz doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lauduz shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lauduz in its N-PORT filings yet. We sweep new filings monthly.